Cornerstone Investment Partners, LLC
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1328062
ATLANTA, GA
Position in TMO
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$45,374,608
-$11,008,194 QoQ
Shares Held
92,313
-5.1% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
2.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Cornerstone Investment Partners, LLC holds $120,688,418 across 6 Diagnostics & Research names. TMO ranks #2 (37.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IQV |
Iqvia Holdings Inc.
|
433,478 | $73,925,338 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
This page
|
92,313 | $45,374,608 | |
| 3 | CRL |
Charles River Laboratories International, Inc.
|
3,594 | $619,965 | |
| 4 | BLLN |
BillionToOne, Inc.
|
3,402 | $268,553 | |
| 5 | VCYT |
Veracyte, Inc.
|
8,043 | $259,065 | |
| 6 | WGS |
GeneDx Holdings Corp.
|
3,751 | $240,889 |
All Filings in TMO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $45,374,608 | 92,313 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $56,382,802 | 97,304 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $41,392,576 | 85,342 | Shares | Sole | 2025-11-06 | |
| 2021-06-30 | $3,026,820 | 6,000 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $2,738,280 | 6,000 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $2,817,969 | 6,050 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $2,693,272 | 6,100 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $2,210,274 | 6,100 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $1,985,200 | 7,000 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||